Lead the company's Finance, Accounting, Legal, and Compliance functions to drive financial performance and strategic decision-making.
Partner with the CEO and leadership team to shape strategy, evaluate business opportunities, and oversee budgeting and forecasting.
Manage commercial finance, pricing, funding, financial systems, stakeholder communication, and risk management across multiple jurisdictions.
Viseven is an AI-native Intelligent Experiences Enabler for life sciences, helping pharma and biotech organizations improve omnichannel engagement with HCPs and patients. The company's clients include Top 50 life sciences, pharma, biotech, and medtech companies globally, and over 50% of the team has been with the company for 5+ years, reflecting a collaborative and supportive culture.
Lead financial strategy, planning, budgeting, and forecasting for both Assail entities.
Oversee accounting, cash management, and financial reporting to support growth.
Partner with the CEO, board, and leadership to drive fundraising and investor diligence.
Assail develops autonomous offensive security platforms powered by sovereign AI, helping organizations test applications and identify exploitable weaknesses. Serving commercial and government clients through two entities, the company operates with a lean, hands-on culture focused on innovation.
Owns the day-to-day finance engine, partnering with R&D, product operations, clinical, and business operations leaders.
Leads budgeting, forecasting, long-range planning, and prepares board and investor reporting packages.
Builds and scales financial infrastructure, accounting operations, internal controls, and a lean finance team.
Brainchild Bio is a clinical-stage biotech developing new therapies for children with brain cancer. Backed by a $116M Series A, the company is headquartered in Seattle and building a growing presence in Texas, with a culture focused on scaling operations through the clinic.